Presentation Information

[F1-16]Integrative Optimization of TLR9 and STING Agonist-Based Strategies in Cancer Immunotherapy

*Mai Onaga1, Burcu Temizoz1, Seigo Akaeda2, Kou Hioki3, Kaiwen Liu1, Tomoya Hayashi1, Hideo Negishi1, Kouji Kobiyama4, Peter D. Katsikis3, Cevayir Coban1, Ken J Ishii1 (1. The University of Tokyo (Japan), 2. Yokohama City University (Japan), 3. Erasmus University Medical Center (Netherlands), 4. University of California San Diego (United States of America))

Keywords:

Cancer,TLR9,STING

Password required to view


Comment

To browse or post comments, you must log in.Log in